Indo US Bio-Tech Faces Valuation Shift Amid Strong Operational Growth and Market Challenges
Indo US Bio-Tech has recently experienced a score adjustment reflecting changes in its financial metrics and market position. Key indicators, including a Price-to-Earnings ratio of 18.06 and a Return on Capital Employed of 19.14%, highlight the company's operational growth despite a challenging year and underperformance relative to market indices.
Indo US Bio-Tech, operating within the Other Agricultural Products sector, has recently undergone an evaluation adjustment that reflects changes in its financial metrics and market position. The stock's score has been revised, indicating a shift in its valuation grade from fair to expensive. This adjustment is primarily attributed to key financial indicators such as a Price-to-Earnings (PE) ratio of 18.06 and an Enterprise Value to EBITDA ratio of 16.23, which suggest a higher valuation relative to its earnings potential.In terms of technical trends, the stock has shown a transition from a mildly bearish outlook to a bearish stance, with various indicators such as the Moving Averages and Bollinger Bands reflecting this change. The company's recent performance has been notable, with a reported Return on Capital Employed (ROCE) of 19.14%, showcasing its efficiency in generating returns from its capital.
Despite a challenging year, where the stock has underperformed compared to broader market indices, Indo US Bio-Tech has demonstrated strong operational growth, with net sales increasing significantly over the past six months. This combination of factors has led to the recent evaluation adjustment, highlighting the complexities of the company's financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
